Biotech is currently one of the most exciting fields in the medical industry. New developments continue evolving at a rapid pace, making it more intriguing than ever. Being in the medical sales field, you’ve seen the impact of life-changing developments.
Now is the time to consider a career in the medical biotech industry as researchers, doctors, and developers create processes that will forever impact treatments and early diagnoses.
Check out these unique developments and how they’re changing the biotech industry:
As medical biotech becomes increasingly complex, it becomes infinitely more refined and the possibilities grow. Biosensors are quickly becoming one of the most fundamental biotech developments and their progress over the next decade will change the face of medicine.
Biosensors are calibrated and designed for uses in various biosignatures, including blood pressure, pulse, breathing, and body temperature. Continued development will revolutionize the current movement in healthcare monitoring and preventative medicine.
Sensible Medical is one of the most noteworthy waymakers in biosensors. The company’s product, a vest monitor, measures lung fluid in heart failure patients, enabling doctors to deliver more accurate and actionable care.
The idea of “printing” has come a long way, and we don’t just mean in the office. Bioprinting emerged into the biotech field around 2010. However, new developments are making waves in the healthcare community.
Today, companies use living cells and 3-D bioprinting to create functioning human body parts, like heart valves, skin, and cartilage.
Many bioprinting companies, like Organovo, have long-term goals of creating whole organs for implantation. The company has already succeeded in providing pharmaceutical companies with printed liver tissue for more accurate drug toxicity testing and is collaborating with the beauty and health industry for other human-like testing products.
There was a time when we couldn’t imagine changing our genes. While it’s true they’re innate, genes are no longer permanent thanks to revolutionary changes in human genome sequencing. As researchers understand our genetics better than ever before, there’s greater scope for manipulating genes to ultimately improve quality of life.
The Swiss-based biotech company, CRISPR Therapeutics is successfully editing genes by cutting out harmful DNA and letting natural DNA processes take over in a two-part system of Cas9 enzyme and a guide RNA.
For example, in initial clinical studies, CRISPR researchers are editing sickle cell disease out of patients’ stem cells with the goal of generating new healthy red blood cells. With more improvements and changes, gene editing has the opportunity to transform the lives of millions with serious diseases.
Of course, we can’t discuss exciting new biotech developments without mentioning the evolution of medications. Thanks to the increased knowledge of genes and cells, manufacturers are making waves in critical areas of the healthcare space.
Oncology drug companies are being asked to put down their rivalries and work together to form biotech regimens that will slow progression and extend survival compared to monotherapies.
In Alzheimer’s, research is now focusing on a protein called tau, one of the root causes of declining brain function. Drugs targeting another protein called amyloid are already on the market. However, a tau-targeting drug, Tauvid, was recently approved to show doctors how much tau is in a patient’s brain.
These types of developments will improve clinical trials and, as a result, help doctors get a more in-depth look into patients’ brains to diagnose and treat Alzheimer’s during its early and critical stages.